Literature DB >> 3493237

Mechanisms by which imipenem may overcome resistance in gram-negative bacilli.

R J Williams, Y J Yang, D M Livermore.   

Abstract

Imipenem is one of the carbapenem class of new beta-lactam antibiotics. It is a potent antibacterial with a broad spectrum of activity. Against Gram-negative rods, it appears to be able to circumvent the classical resistance mechanisms by way of its high affinity for PBP 2 and its good penetration of the cell wall. Imipenem is stable to hydrolysis by the common plasmid-mediated beta-lactamases and is a potent inducer of, but stable to the action of, chromosomal beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3493237     DOI: 10.1093/jac/18.supplement_e.9

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem.

Authors:  L E Adinolfi; P F Bonventre
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

2.  Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/Relebactam in Complicated Infections: A Meta-analysis.

Authors:  Syeda Sahra; Abdullah Jahangir; Rachelle Hamadi; Ahmad Jahangir; Allison Glaser
Journal:  Infect Chemother       Date:  2021-06

3.  Rapid Detection of Imipenem Resistance in Gram-Negative Bacteria Using Tabletop Scanning Electron Microscopy: A Preliminary Evaluation.

Authors:  Gabriel Haddad; Anthony Fontanini; Sara Bellali; Tatsuki Takakura; Yusuke Ominami; Akiko Hisada; Linda Hadjadj; Jean-Marc Rolain; Didier Raoult; Jacques Yaacoub Bou Khalil
Journal:  Front Microbiol       Date:  2021-06-16       Impact factor: 5.640

4.  Combined ceftazidime and amikacin resistance among Gram-negative isolates in acute-onset postoperative endophthalmitis: prevalence, antimicrobial susceptibilities, and visual acuity outcome.

Authors:  Animesh Jindal; Avinash Pathengay; Manav Khera; Subhadra Jalali; Annie Mathai; Rajeev Reddy Pappuru; Raja Narayanan; Savitri Sharma; Taraprasad Das; Harry W Flynn
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-10-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.